Health

FDA Approves Papzimeos (zopapogene imadenovec-drba) for the Treatment of Adults with Recurrent Respiratory Papillomatosis

DailyTrendDailyTrend
Aug 18, 2025 - 09:00
 0  0
FDA Approves Papzimeos (zopapogene imadenovec-drba) for the Treatment of Adults with Recurrent Respiratory Papillomatosis
GERMANTOWN, Md, Aug. 15, 2025 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced that the US Food and Drug...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

B. Braun Medical Issues Voluntary Nationwide Recall of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL Due to the Presence of Particulate Matter

B. Braun Medical Issues Voluntary Nationwide Recall of ...

DailyTrend Aug 20, 2025  0  0

Congo Has Astronomical Rates of Sexual Violence. Now Vi...

DailyTrend Aug 22, 2025  0  0

A 1990 Measles Outbreak Shows How the Disease Can Roar Back

A 1990 Measles Outbreak Shows How the Disease Can Roar ...

DailyTrend Aug 21, 2025  0  0

Was Head-Binding an Ancient Way to Get Ahead?

DailyTrend Aug 22, 2025  0  0

Sport Psychology Tips for Everyday Life

Sport Psychology Tips for Everyday Life

DailyTrend Aug 21, 2025  0  0

What to Know About Plague After a New Case in California

What to Know About Plague After a New Case in California

DailyTrend Aug 22, 2025  0  0